Multi-state cannabis corporation, Vireo Wellness International, Inc. has announced the approval of their patent application for “Tobacco Solutions with Cannabinoid Additives and Procedures for Minimizing the Harm Linked with Tobacco Use.”

Vireo announced on Thursday that they had received a Notice of Allowance from the United States Patent and Trademark Workplace, signaling the completion of the final step in the approval method.

Vireo says that utilizing cannabinoid additives in tobacco items is linked with lowered inflammation, irritation, and carcinogenicity.

“This patent is a element of our approach to disrupt the tobacco business and enable save lives,” stated Vireo CEO, Kyle Kingsley, MD in a statement. “As a doctor, I am passionate about obtaining methods to use cannabis to minimize the dangerous effects of tobacco.”

According to the Centers for Illness Manage, tobacco is the top preventable trigger of death in the United States and has a important annual effect on healthcare fees reaching into the hundreds of billions of dollars.

Vireo’s new patent covers the use of cannabis-primarily based, harm-reduction agents created to be added to cigarettes, cigars, pipes, and smokeless tobacco items.

“We appear forward to collaborating with study institutions and tobacco organizations committed to creating much less dangerous tobacco items,” stated Kingsley.

A Spanish study released in 2016 concluded that there is a big quantity of scientific proof to show that THC and other cannabinoids exhibit anticancer properties in preclinical models of cancer.